Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Change in Accured Expenses: 2010-2024

Historic Change in Accured Expenses for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $639063.0.

  • Cryo Cell International's Change in Accured Expenses rose 2749.67% to -$389123.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$5.0 million, marking a year-over-year decrease of 3349.77%. This contributed to the annual value of $639063.0 for FY2024, which is 5960.76% down from last year.
  • Latest data reveals that Cryo Cell International reported Change in Accured Expenses of $639063.0 as of FY2024, which was down 5960.76% from $1.6 million recorded in FY2023.
  • Cryo Cell International's Change in Accured Expenses' 5-year high stood at $1.6 million during FY2023, with a 5-year trough of $11275.0 in FY2021.
  • In the last 5 years, Cryo Cell International's Change in Accured Expenses had a median value of $639063.0 in 2024 and averaged $770605.6.
  • In the last 5 years, Cryo Cell International's Change in Accured Expenses plummeted by 9896.76% in 2021 and then soared by 458668.74% in 2022.
  • Cryo Cell International's Change in Accured Expenses (Annual) stood at $1.1 million in 2020, then tumbled by 98.97% to $11275.0 in 2021, then surged by 4586.69% to $528424.0 in 2022, then skyrocketed by 199.41% to $1.6 million in 2023, then plummeted by 59.61% to $639063.0 in 2024.
  • Its last three reported values are $639063.0 in FY2024, $1.6 million for FY2023, and $528424.0 during FY2022.